Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia (NCT03527992) | Clinical Trial Compass
RecruitingNot Applicable
Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
France128 participantsStarted 2018-03-09
Plain-language summary
Hypoxemic pneumonia is a major cause of hospitalization in Pulmonology. The patient's dependency on oxygen prevents early discharge from the hospital. An automated oxygen therapy is a system that allows administration of oxygen with a flow that is automatically adjusted to the patient's saturation, which is continuously monitored. This system has proven to be particularly effective with chronic obstructive pulmonary disease (COPD) patients, by decreasing the time spent in hypoxia and hyperoxia, and by accelerating the weaning of oxygen. Our hypothesis is that automated oxygen therapy leads to a diminution on the length of hospital stay.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult
* Patient living at home or in an institution
* Patient hospitalized for less than 48 hours
* Pneumonia defined (according to the 2006 French-speaking infectious pneumology society (SPILF) criteria) by:
* respiratory functional symptoms (cough, sputum, dyspnea, chest pain) and
* Hyperthermia \>38,5°C or hypothermia \<36°C and
* Radiological Signs of Pneumonia
* Hypoxia : SpO2 \< 94% in ambient air and/or PaO2\< 60 mmHg in ambient air
Exclusion Criteria:
* Pneumonia acquired at the hospital.
* Patient hospitalized in another department more than 48 hours before admission
* Chronic respiratory failure
* Active neoplasia
* Patients undergoing oxygen therapy and / or long-term NIV
* Associated cardiac decompensation (clinical signs and / or NTproBNP\> 1800ng / mL) (3
* Initial Need for high flow oxygen therapy or ventilatory support (NIV, VI)
* Difficulties expected from home support.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.